Supplements · Diets · Metabolic & Cardiometabolic
garlic decreases fasting blood glucose
In plain terms: Does garlic lower blood sugar?
Part of: 🧪 Garlic
Probably a little, in people with type 2 diabetes — studies consistently point the same way (fasting glucose down ~7–12 mg/dL). But the trials are small, low-quality, and wildly inconsistent in size, so treat it as a modest, uncertain add-on, not a real glucose treatment.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Across multiple meta-analyses of type-2-diabetes trials, garlic consistently lowers fasting blood glucose (~7–12 mg/dL) and HbA1c. Direction is consistent but certainty is low — the trials are small, mostly low-quality, and extremely heterogeneous (I² up to 99%), so the true magnitude is uncertain.
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Ebrahimzadeh A et al. 2026 · Nutr Metab Insights | meta-analysis | supports | low | Meta 8 RCTs in T2D: FBS -12.4 mg/dL, HbA1c -0.5%; authors flag low study quality and extreme heterogeneity (I2 96-99%). |
| Kumar R et al. 2013 · Diabetes Metab Syndr Obes | RCT | supports | low | Open-label n=60: metformin+garlic vs metformin - greater FBG/PPG reduction but HbA1c change NOT significant. ↩ SUPERSEDED — pooled in the review above, counted once |
| Singh A et al 2026 · study_type: animal | animal | supports | low | STZ-induced T2D male rats fed garlic 60 mg/day for 28 days; blood glucose significantly reduced at 30 and 120 min of OGTT vs diabetic controls, alongside improved lipids and antioxidant markers. |
| Hesari NG et al 2025 · study_type: RCT | RCT | supports | high | RCT, 97 women with PCOS+metabolic syndrome; garlic tablets (500 mg, 2-3 mg allicin, twice daily, 8 weeks) reduced fasting blood sugar by 10.5% (107.2→95.9 mg/dL, P<0.001) vs placebo, plus improved lipids/CRP/BP. |
| Sobenin IA et al. 2007 · Acta Diabetol | RCT | supports | moderate | RCT n=60: time-released garlic lowered fasting glucose + fructosamine + triglycerides vs placebo over 4 wk. |
| Mejía Delgado EM et al 2025 · study_type: observational | observational | supports | low | Narrative review (PubMed/EMBASE/Scielo) of Allium sativum in T2D; states clinical evidence supports reductions in fasting glucose, HbA1c, blood pressure, and oxidative stress, but does not pool or quantify effect sizes. |
| Zhao X et al. 2024 · Nutrients | meta-analysis | supports | moderate | Meta: fasting glucose -7.0 mg/dL, HbA1c -0.66% in mixed adults (moderate HbA1c heterogeneity). |
| Hou LQ et al. 2015 · Asia Pac J Clin Nutr | meta-analysis | supports | moderate | Meta 7 RCTs (513, mixed diabetic/non-diabetic): fasting glucose lowered (SMD -1.67); too few studies to pool HbA1c reliably. |
| Alsanie SA et al 2026 · study_type: meta-analysis | meta-analysis | supports | moderate | GRADE-assessed dose-response meta-analysis, 27 RCTs, n=1619; garlic supplementation reduced FBG (WMD -2.76 mg/dL, 95% CI -5.11 to -0.41) and HbA1c (WMD -0.53%, 95% CI -0.86 to -0.20). No significant effect on insulin or HOMA-IR; greater FBG |
| Wang J et al. 2017 · Food Nutr Res | meta-analysis | supports | low | Meta 9 RCTs (768 T2D, allicin-standardized): dose/time-dependent fasting-glucose reduction plus lower fructosamine and HbA1c. |
| Ashraf R et al. 2011 · Pak J Pharm Sci | RCT | supports | low | Small single-center RCT (n=60 T2D on metformin): modest extra fasting-glucose reduction vs placebo over 24 wk. ↩ SUPERSEDED — pooled in the review above, counted once |
| Behrouz V et al. 2026 · Nutr Rev | meta-analysis | supports | high | Meta 108 RCTs (n=7137): FBG -2.77 mg/dL, insulin -1.74, HOMA-IR -0.37; stronger in unfavorable-baseline; more high-quality RCTs needed. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.